Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional Experience

Dandriyal, Ramakant; Lal, Vishakha; Giri, Kolli Yada; Bavanthabettu, Niranjanaprasad Indra; Chaurasia, Archana; Pant, Swati

doi:10.1007/s12663-022-01694-6

Cited by 6 publications

(6 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding the histological subtype, the mural variant was observed more frequently among the study samples, which has also been found by other authors 3,10 . The mural subtype samples affected predominantly females (77%; n = 9), aged between the second and fourth decades of life (mean: 28.78 years).…”

Section: Discussionsupporting

confidence: 87%

“…[4][5][6][7] From the demographic point of view, our unicystic ameloblastoma cases were predominantly observed in patients between the second and third decades of life, which is similar to other studies, 8,9 and in female individuals, contrary to what is observed in the literature. 2,10,11 This difference regarding gender can be explained by the reduced sample size.…”

Section: Discussionmentioning

confidence: 99%

“…Regarding the histological subtype, the mural variant was observed more frequently among the study samples, which has also been found by other authors. 3,10 The mural subtype samples affected predominantly females (77%; n = 9), aged between the second and fourth decades of life (mean: 28.78 years). The lesions were predominantly unilocular (89%; n = 8), located at the posterior region of the mandible in all but one case and their dimensions ranged between 31 and 77 mm (mean: 47.67 mm).…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

A conservative approach for unicystic ameloblastoma: Retrospective clinic‐pathologic analysis of 12 cases

Leite-Lima

Martins‐Chaves

Fonseca

et al. 2023

J Oral Pathology Medicine

View full text Add to dashboard Cite

BackgroundUnicystic ameloblastoma is an encapsulated odontogenic neoplasm with a single cyst cavity. The conservative or aggressive surgical approaches used to treat the tumor directly affect recurrence rates. However, there is a lack of a standard protocol that can guide its management.Study DesignWe retrospectively reviewed the clinicopathological findings and therapeutical procedures of 12 unicystic ameloblastoma cases treated by the same surgeon during the past 20 years.MethodsAll cases of unicystic ameloblastoma diagnosed by biopsy and treated by the same surgeon between 2002 and 2022 were reviewed. Eligibility criteria were patients with completely filled‐out charts containing the follow‐up period and confirmation of the diagnoses based on the microscopic findings of the whole excised specimens. Data collected were categorized into clinical, radiographic, histological, surgical, and recurrence aspects.ResultsThere was a female predilection (2:1), and ages ranged between 18 and 61 years (mean: 27.25, ±12.45). Almost all (92%) affected the posterior mandible. Radiographically, the mean length of the lesions was 46.14 mm ± 14.28 mm which 92% were unilocular and 8.3% multilocular. Root resorption (n = 7, 58%), tooth displacement (n = 9, 75%), and cortical perforation (n = 5, 42%) were also observed. The mural histological subtype corresponded to 9 (75%) of the cases. The same conservative protocol was performed in all cases. The follow‐up period ranged between 12 and 240 months (~62 ± 65) and recurrence occurred in only one patient (8%).ConclusionOur findings suggest a conservative approach should be the first option for unicystic ameloblastoma treatment, even for those with mural proliferation.

show abstract

Section: Discussionsupporting

confidence: 87%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A conservative approach for unicystic ameloblastoma: Retrospective clinic‐pathologic analysis of 12 cases

Leite-Lima

Martins‐Chaves

Fonseca

et al. 2023

J Oral Pathology Medicine

View full text Add to dashboard Cite

show abstract

“…In general, it has been shown that the average age of presentation of AM ranges between the fourth and fifth decade of life [ 3 ], with a maximum age of 79 years, according to the data reported in this research. In Europe, the mean age has been reported to be 48.2 years [ 67 ]; in North America, 40.7 years [ 68 ]; in South America, 35.1 years [ 69 ]; in Africa, 31.3 years [ 70 ] and in Asia 30.35 years [ 71 ]. There is no gender predilection, although a slight male predominance has been reported, with a male-to-female ratio 3:2 [ 70 ].…”

Section: Discussionmentioning

confidence: 99%

“…The presence of swelling, ulceration, malocclusion, mobility, and loss of teeth are these patients’ most frequent clinical manifestations [ 8 ]. Radiographically, the radiolucent and multilocular appearance is the most common, followed by the unilocular appearance [ 9 , 71 ]. Furthermore, these lesions are characterized by displacement of adjacent teeth, root resorption, and bone expansion [ 67 , 75 ].…”

Section: Discussionmentioning

confidence: 99%

Implant-supported prosthetic rehabilitation after Ameloblastomas treatment: a systematic review

Alarcón-Sánchez,

Becerra-Ruíz,

Yessayan

et al. 2023

BMC Oral Health

View full text Add to dashboard Cite

Background Ameloblastoma (AM), the benign counterpart of ameloblastic carcinoma, is a benign odontogenic tumor of epithelial origin, naturally aggressive, with unlimited growth potential and a high tendency to relapse if not adequately removed. Patients with AM treated surgically can benefit from dental implant therapy, promoting oral rehabilitation and improving their quality of life. The present study aimed to determine the survival rate of dental implants placed after surgical treatment of patients affected by AM. In addition, there were two secondary objectives: 1) To evaluate which dental implant loading protocols are most frequently used and 2) To determine the type of prosthetic restoration most commonly used in these patients. Methods The Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines were followed during the study. Searches were performed in three databases (PubMed/MEDLINE, Scopus, and Google Scholar) until November 2023. Additionally, the electronic search was enriched by an iterative hand search of journals related to oral pathology and medicine, maxillofacial surgery, and oral prosthodontics and implantology. Only reports and case series in English from January 2003 to date were included. The Joanna Briggs Institute tool (JBI-Case Reports/Case Series) was used for the study quality assessment. Results The total number of patients and implants studied were 64 and 271, respectively, all with surgically treated AM. The patient’s ages ranged from 8 to 79 years, with a mean (SD) age of 37.3 ± 16.4. Fifty-three percent were male and 47% were female. The range of follow-up duration was 1 to 22 years. An implant survival/success rate of 98.1% was reported. In addition, most of them were conventionally loaded (38.3%). Hybrid implant-supported fixed dentures were the most commonly used by prosthodontists (53%). Conclusions Oral rehabilitation with dental implants inserted in free flaps for orofacial reconstruction in surgically treated patients with AM can be considered a safe and successful treatment modality.

show abstract

Factors Associated with Recurrence of Ameloblastoma: A Scoping Review

Inthong,

Upalananda,

Saepoo

2024

Head and Neck Pathol

View full text Add to dashboard Cite

Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional Experience

Cited by 6 publications

References 40 publications

A conservative approach for unicystic ameloblastoma: Retrospective clinic‐pathologic analysis of 12 cases

A conservative approach for unicystic ameloblastoma: Retrospective clinic‐pathologic analysis of 12 cases

Implant-supported prosthetic rehabilitation after Ameloblastomas treatment: a systematic review

Factors Associated with Recurrence of Ameloblastoma: A Scoping Review

Contact Info

Product

Resources

About